Patent pending. Clinical validation in development.
NUWAC.COM

INVESTOR ACCESS

The next category is not better monitoring.
It is guided correction.

NUWAC is building the connective layer between gait data, clinician intent, real-time biofeedback, and structured evidence.

Request confidential briefing
NUWAC / INVESTOR THESISPATENT PENDING · PRIVATE MATERIALS AVAILABLE BY REQUEST
01 / THE CATEGORY GAP

Measurement and correction remain disconnected.

Wearables can collect increasingly rich movement data. Rehabilitation still depends on timely interpretation, a defined goal, and a response the person can understand and act on.

Passive movement capture
Clinician-guided feedback execution
A dashboard after the session
A cue inside the movement
A device-specific dataset
A structured session architecture
One isolated indication
A configurable gait platform direction
02 / DEFENSIBILITY

The moat is the relationship between layers.

Detailed implementation is reserved for confidential review. Publicly, the thesis is clear: value compounds as clinical workflow, adaptive execution, continuity, and structured evidence operate as one system.

Structured session data
Clinical + research workflow
Adaptive execution + continuity
Clinician-guided
feedback loop
Platform thesis

A feedback operating layer

The platform connects wearable sensing with calibration, clinician-defined objectives, real-time guidance, session state, and review.

Market direction

Multiple gait-related pathways

The architecture is intended to support research and development across neurologic, orthopedic, and human-performance applications without claiming validated indications.

Data direction

Evidence-bearing sessions

Structured traces create a path toward candidate gait biomarkers, clinical partnerships, and repeatable evidence generation.

Workflow position

Clinician intent stays upstream

NUWAC is designed to extend configured rehabilitation guidance into movement, while preserving professional oversight and later review.

Development stage

Research-stage, patent pending

Engineering development and clinical validation are in progress. Technical architecture, plans, and patent-sensitive detail are available through a confidential briefing.

04 / PRIVATE ACCESS

See the system behind the signal.

Request a focused conversation about the platform thesis, development pathway, intellectual-property position, validation direction, and partnership opportunities.

Briefings reviewed by the NUWAC team

Request investor briefing

Tell us enough to route the conversation appropriately.